Case number 1:19-cv-00132
Genentech, Inc. et al v. ScieGen Pharmaceuticals Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 9, 2020 | 1 | Complaint (20) |
| Aug 21, 2019 | 21 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,383,150 B2; 8,420,674 B2; 7,767,225 B2; 7,988,994 B2; 8,753,679 B2. (Attachments: # (1) Order)(nms) |
| Aug 21, 2019 | 21 | Order (2) |
| Aug 21, 2019 | 21 | Patent/Trademark Report to Commissioner (1) |
| Aug 20, 2019 | 20 | Order (2) Docket Text: SO ORDERED Granting [19] Proposed Consent Order of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 8/20/2019. (nms) |
| Aug 20, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 8/20/2019. Local counsel present for plaintiffs: J. Blumenfeld. Local counsel present for defendants: S. Brauerman, A. Orlacchio, S. O'Byrne, S. Stamoulis, A. Gaza, E. Ormerod, B. Schladweiler, J. Parshall, M. Haney, K. Dorsney. (Court Reporter Heather Triozzi.) Associated Cases: 1:19-cv-00078-RGA et al.(crb) |
| Aug 15, 2019 | 19 | Proposed Consent Judgment (2) Docket Text: PROPOSED Consent Order of Dismissal, by ScieGen Pharmaceuticals Inc.. (Rogowski, Patricia) Modified on 8/20/2019 (nms). |
| Jul 23, 2019 | 18 | Notice of Substitution of Counsel (2) Docket Text: NOTICE OF SUBSTITUTION OF COUNSEL re ScieGen Pharmaceuticals Inc.: Entry of appearance of attorney Patricia Smink Rogowski. Attorney R. Touhey Myer and Salvatore Guerriero terminated. (Rogowski, Patricia) |
| May 16, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER SETTING RULE 16(b) CONFERENCE: A scheduling conference pursuant to Fed. R. Civ. P. 16(b) will be held on Tuesday, August 20, 2019, at 2:30 p.m., in Courtroom 6A of the Boggs Federal Building, 844 King Street, Wilmington, Delaware. Plaintiffs counsel shall coordinate a dial in number for all parties wishing to participate, but not physically being able to do so. The dial in number will be for listening capacity only. Parties shall confer about scheduling and discovery limitations, and attempt to reach agreement. The parties shall use as a basis for discussion the Courts Rule 16 Scheduling Order patent, available on the Courts website. No later than 48 hours before the scheduling conference, the parties shall file a proposed scheduling order using the Rule 16 Scheduling Order - patent. The parties shall direct any requests or questions regarding the scheduling or management of this case to the Courts Case Manager at (302) 573-6137. Ordered by Judge Richard G. Andrews on 5/16/2019. Associated Cases: 1:19-cv-00078-RGA et al.(nms) |
| Apr 2, 2019 | 16 | Answer to Counterclaim (12) Docket Text: ANSWER to [15] Answer to Complaint, and Counterclaims, by Genentech, Inc., InterMune, Inc..(Jacobs, Karen) Modified on 4/2/2019 (nms). |
| Mar 12, 2019 | 15 | Answer to Complaint (20) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, and COUNTERCLAIMS against All Plaintiffs, by ScieGen Pharmaceuticals Inc..(Myer, R.) Modified on 3/13/2019 (nms). |
| Mar 8, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Ryan Hagglund, Warren K. MacRae, and Mark E. Waddell for Genentech, Inc. and InterMune, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00078-RGA et al.(ddp) |
| Mar 7, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [14] Stipulation and Order of Dismissal (*Party Bactolac Pharmaceutical Inc. terminated). Signed by Judge Richard G. Andrews on 3/7/2019. (nms) |
| Mar 6, 2019 | 14 | Stipulation of Dismissal (3) Docket Text: STIPULATION of Dismissal without Prejudice, by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) Modified on 3/7/2019 (nms). |
| Feb 12, 2019 | N/A | SO ORDERED (0) |
| Feb 11, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Feb 11, 2019 | 13 | Motion for Leave to Appear Pro Hac Vice (15) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Mark E. Waddell, Warren K. MacRae and Ryan Hagglund of LOEB & LOEB LLP - filed by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) |
| Feb 8, 2019 | N/A | SO ORDERED (0) |
| Feb 8, 2019 | 12 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Robert Silver and Salvatore Guerriero of Caesar Rivise, PC - filed by Bactolac Pharmaceutical Inc., ScieGen Pharmaceuticals Inc.. (Myer, R.) |
| Feb 7, 2019 | N/A | SO ORDERED (0) |
| Feb 7, 2019 | 11 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for Defendants to answer the Complaint to March 15, 2019 - filed by Bactolac Pharmaceutical Inc., ScieGen Pharmaceuticals Inc.. (Myer, R.) |
| Feb 7, 2019 | 10 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Bactolac Pharmaceutical Inc.. (Myer, R.) |
| Feb 7, 2019 | 9 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Bactolac Pharmaceutical Inc. for ScieGen Pharmaceuticals Inc. filed by ScieGen Pharmaceuticals Inc.. (Myer, R.) |
| Feb 7, 2019 | 8 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by R. Touhey Myer on behalf of Bactolac Pharmaceutical Inc., ScieGen Pharmaceuticals Inc. (Myer, R.) |
| Jan 30, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:19-cv-00120-RGA, 1:19-cv-00123-RGA, 1:19-cv-00130-RGA through 1:19-cv-00132-RGA, 1:19-cv-00136-RGA, 1:19-cv-00141-RGA, 1:19-cv-00142-RGA, 1:19-cv-00154-RGA and 1:19-cv-00164-RGA (rjb) |
| Jan 25, 2019 | 7 | Declaration (9) Docket Text: DECLARATION of Mailing, by Genentech, Inc., InterMune, Inc.. (Blumenfeld, Jack) Modified on 1/30/2019 (nms). |
| Jan 24, 2019 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by InterMune, Inc., Genentech, Inc.. Bactolac Pharmaceutical Inc. served on 1/24/2019, answer due 2/14/2019. (Blumenfeld, Jack) |
| Jan 24, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Bactolac Pharmaceutical Inc. on 1/24/2019; ScieGen Pharmaceuticals Inc. on 1/24/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg) |
| Jan 23, 2019 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Roche Holdings, Inc. for Genentech, Inc.; Other Affiliate Genentech, Inc. for InterMune, Inc. filed by Genentech, Inc., InterMune, Inc. (ceg) |
| Jan 23, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,383,150 B2; 8,420,674 B2; 7,767,225 B2; 7,988,994 B2; 8,753,679 B2. (ceg) |
| Jan 23, 2019 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/11/2018. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 4/15/2022. (ceg) |
| Jan 23, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
| Jan 23, 2019 | 1 | Civil Cover Sheet (2) |
| Jan 23, 2019 | 1 | Main Document (20) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Bactolac Pharmaceutical Inc., ScieGen Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. (Filing fee $ 400, receipt number 0311-2551039.) - filed by InterMune, Inc., Genentech, Inc. (Attachments: # (1) Exhibits 1-5, # (2) Civil Cover Sheet)(ceg) |
| Jan 23, 2019 | 1 | Exhibits 1-5 (98) |
| Jan 23, 2019 | 1 | Complaint* (1) |
